MEDICAL BIO WARFARE DEFENSE PLAN 8 APR 91

File: 970101_sep96_decls1_0009.txt
Page: 0009
Total Pages: 194

Subject: MEDICAL BIO WARFARE DEFENSE PLAN  8 APR 91                      

Unit: OTSG        

Parent Organization: HSC         

Box  ID: BX003202

Folder Title: MEDICAL BIOLOGICAL WARFARE - BW- DEFENSE PLAN                                                   

Document Number:          2

Folder Seq  #:         25





                                          C% r
                                                      UNCLASSIFIED





                                   ,;ill be stockpiled based on force strength
          data in para la. Vaccinia Immune Globulin which is used to counter
          adverse effects of smallpox vaccination will also be stockpiled.

              c.  @ Anthrax and botulinum vaccine and antitoxin
          requirements (doses):                                   5 USC 522(b)(1)
                              Anthrax     Botulinum     BotUlinum
                              vaccine      Vaccine      Antitoxin


                  Army
                  Air Force
                  Navy

          2. (Ti) Establish the Joint Medical Biological Warfare Defense
          Committee (JMBWDC) to make decisions on vaccination of U.S. Forces
          against BW agents. Army -membership will include representatives
          from DCSOPS, OTSG, and DCSINT. Other services should have
          representatives from similar functional areas. Executive Agent
          will be Army. objective is to address Medical BW Defense as a
          normal course of readiness and preparation of the force for war.

          3. (U) immunize the services' designated early deploying forces
          during peacetime against specific BW agents to maximize readiness
          and deployment posture. Funding for vaccines and toxoids is a
          service responsibility. Amend the Tri-Service regulation AR
          40-526/NAVMEDCOMINST 6230.3/AFR 161-13ICG COMDTINST M6230.4D,
          Immunizations and Chemoprophylaxis, to reflect this.
                                                                  5 USC 522(b)(1)
          4. @ Establish a government owned contractor operated (GOCO)
          facility to produce vaccines, toxoids, and antitoxin to support DoD
          missions. During operation Desert Shield all capable U.S. vaccine
          producers were requested to state their willingness to produce
        botulinum va(
          I                gh efforts in renovations, contract negotiations,
          an compl ance  with Food and Drug Administration regulations have
          been accelerated, production of vaccines is not responsive to the
          operational needs. It is recommended that a GOCO facility be
          established which can be directed immediately to produce vaccines,
          toxoids, and antitoxins against eminent BW threats in future wars.

          5.      Decentralize storage of vaccines for security pur oses.
                                                                    5'OSC 522(b)(1)



                                             2


                                                 T UNCLASSIFIED

Document 194 f:/Week-36/BX003202/MEDICAL BIOLOGICAL WARFARE - BW- DEFENSE PLAN/medical bio warfare defense plan 8 apr 91:1224960931152
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003202
Unit = OTSG
Parent Organization = HSC
Folder Title = MEDICAL BIOLOGICAL WARFARE - BW- DEFENSE PLAN
Folder Seq # = 25
Subject = MEDICAL BIO WARFARE DEFENSE PLAN 8 APR 91
Document Seq # = 2
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 24-DEC-1996